Today's noteworthy initiations include: Adamis Pharmaceuticals (ADMP) initiated with a Buy at Maxim... Alstom (ALSMY) initiated with a Neutral at Citi... Avago (AVGO) initiated with a Positive at Susquehanna... BG Staffing (BGSF) initiated with a Buy at Roth Capital... Blackhawk (HAWK) initiated with an Overweight at First Analysis... CDW Corporation (CDW) initiated with a Buy at Goldman... CSRA (CSRA) initiated with a Neutral at SunTrust... Communications Sales & Leasing (CSAL) initiated with an Outperform at Raymond James... ConforMIS (CFMS) initiated with a Buy at Sterne Agee CRT... Cott Corp. (COT) initiated with a Buy at Canaccord... Dominion Midstream (DM) initiated with a Buy at Evercore ISI... El Pollo Loco (LOCO) initiated with a Buy at Guggenheim... Electrolux AB (ELUXY) initiated with a Neutral at Citi... Eversource (ES) initiated with a Neutral at Citi... Gastar Exploration (GST) initiated with a Buy at Canaccord... Habit Restaurants (HABT) initiated with a Buy at Guggenheim... Keysight Technologies (KEYS) initiated with a Hold at Deutsche Bank... Leucadia (LUK) initiated with an Outperform at Oppenheimer... NRG Energy (NRG) initiated with a Sell at Citi... NRG Yield (NYLD) initiated with a Buy at Citi... Parsley Energy (PE) initiated with a Buy at BofA/Merrill... Profire Energy (PFIE) initiated with a Buy at Roth Capital... Questar (STR) initiated with a Neutral at UBS... Sibanye Gold (SBGL) initiated with a Sector Perform at RBC Capital... Siemens (SIEGY) initiated with a Buy at Citi... Starwood Property (STWD) initiated with an Outperform at JMP Securities... TG Therapeutics (TGTX) initiated with an Outperform at FBR Capital... Ultragenyx (RARE) initiated with a Buy at Stifel... Vertex (VRTX) initiated with a Buy at Stifel... Wingstop (WING) initiated with a Buy at Guggenheim... Xerox (XRX) initiated with a Neutral at Goldman... uniQure (QURE) initiated with a Buy at Janney Capital.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here

Expects 2024 adjusted operating margin of at least 7.5%. Maintains three-year target of $300M of incremental adjusted operating income above 2023 levels and a return to double-digit adjusted operating income margin by 2026.

Vertex Pharmaceuticals and TreeFrog Therapeutics announced that Vertex has obtained an exclusive license to TreeFrog's proprietary cell manufacturing technology, C-Stem, to optimize production of Vertex's cell therapies for type 1 diabetes, or T1D. TreeFrog and Vertex will collaborate to scale-up TreeFrog's process to produce and amplify cells for Vertex's T1D therapies. TreeFrog's proprietary technology platform, C-Stem, is designed to mimic the natural microenvironment, allowing cells to grow exponentially in 3D. The technology will enhance Vertex's ability to generate large amounts of fully differentiated cells for its portfolio of T1D cell therapies.